Ear, nose, and throat surgeon Pathologist (eg, dermatopathologist and general surgical, head and neck, or oral and maxillofacial specialist) Medical and radiation oncologists Maxillofacial prosthodontists Speech therapist The primary concern is ensured surgical removal
Until that evidence exists, semaglutide is the only one of the two with proven cardiovascular benefit
This aggressive start is important for those with big deficiencies
The stomach area offers the largest surface area of any approved injection site, which means more room for rotation and less chance of hitting the same spot twice
Moreover, in a hyperglycemic ApoE gene knockout mouse model, liraglutide was found to inhibit atherosclerosis through an AMPK-independent mechanism, suggesting that GLP-1 receptor agonists may exert cardiovascular protective effects through multiple mechanisms ( FIGURE 3 Preliminary evidence also suggests that tirzepatide may confer cardiovascular benefits by improving lipid metabolism (e.g., lowering LDL cholesterol) and reducing inflammation (e.g., lowering C-reactive protein)
Research is investigating its effects on non-alcoholic steatohepatitis (NASH), cardiovascular outcomes, and its role in reducing the risk of developing type 2 diabetes in individuals with prediabetes